Update on recent developments for patients with newly diagnosed multiple myeloma.
Ann N Y Acad Sci
; 1138: 19-21, 2008 Sep.
Article
em En
| MEDLINE
| ID: mdl-18837878
ABSTRACT
Recent studies have demonstrated that novel therapeutic combinations are challenging melphalan and prednisone (MP) as the standard of care in elderly patients with multiple myeloma. Combination regimens containing bortezomib or thalidomide can achieve response rates, especially complete response rates, which are superior to those seen with standard MP alone, and offer new possibilities for this patient population.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Protocolos de Quimioterapia Combinada Antineoplásica
/
Mieloma Múltiplo
Tipo de estudo:
Diagnostic_studies
Limite:
Aged
/
Humans
Idioma:
En
Revista:
Ann N Y Acad Sci
Ano de publicação:
2008
Tipo de documento:
Article